Orexo AB (ORX)

Stockholm
Currency in SEK
19.4
-0.1(-0.51%)
Closed
ORX Scorecard
Full Analysis
Impressive gross profit margins
Fair Value
Day's Range
19.119.8
52 wk Range
9.224.0
Key Statistics
Edit
Prev. Close
19.5
Open
19.5
Day's Range
19.1-19.8
52 wk Range
9.2-24
Volume
27.8K
Average Volume (3m)
43.88K
1-Year Change
31.08%
Book Value / Share
-0.79
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
ORX Scorecardpro icon
Company’s Health
pro lockUnlock
Fair Value
pro lockUnlock Price
Fair Pricepro lock
Upsidepro lock
Analysts Sentiment
Currently not supported.
Members' Sentiments
Bearish
Bullish
ProTips
Analysts do not anticipate the company will be profitable this year
Show more

Orexo AB Company Profile

Orexo AB (publ), a specialty pharmaceutical company, develops and commercializes pharmaceuticals and digital therapies in the United States, European Union, and internationally. Its products include Zubsolv tablets for the treatment of opioid use disorder; Abstral for the treatment of breakthrough pain in cancer patients; and Edluar for the treatment of insomnia. The company is developing OX124 for opioid overdose; OX125 for rescue medication and opioid overdose; OX640 for emergency treatment of allergic reactions; and OX-MPI for the treatment of endometriosis. In addition, its digital therapies include deprexis for the treatment of depression; vorvida for alcohol management; and modia for opioid use disorder. The company has a collaboration agreement with Abera Bioscience AB to develop nasal powder vaccines based on the AmorphOX technology. Orexo AB (publ) was founded in 1994 and is headquartered in Uppsala, Sweden.

Employees
113
Market
Sweden

Compare ORX to Peers and Sector

Metrics to compare
ORX
Peers
Sector
Relationship
P/E Ratio
−6.3x−3.4x−0.6x
PEG Ratio
−0.13−0.110.00
Price/Book
−24.4x4.5x2.6x
Price / LTM Sales
1.1x10.7x3.1x
Upside (Analyst Target)
1.8%57.6%55.4%
Fair Value Upside
Unlock2.6%10.2%Unlock

FAQ

What Is the Orexo AB (ORX) Stock Price Today?

The Orexo AB stock price today is 19.40

What Stock Exchange Does Orexo AB Trade On?

Orexo AB is listed and trades on the Stockholm stock exchange.

What Is the Stock Symbol for Orexo AB?

The stock symbol for Orexo AB is "ORX."

What Is the Orexo AB Market Cap?

As of today, Orexo AB market cap is 668.71M.

What is Orexo AB Earnings Per Share?

The Orexo AB EPS is -3.05.

What Is the Next Orexo AB Earnings Date?

Orexo AB will release its next earnings report on Feb 05, 2025.

From a Technical Analysis Perspective, Is ORX a Buy or Sell?

Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Buy.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2025 - Fusion Media Limited. All Rights Reserved.